SMTL ID : 7q85.1

Crystal structure of human STING in complex with MD1193

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.36 Å

Oligo State

homo-dimer

Ligands

2 x 98F: 9-[(1R,6R,8R,13E,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3,12-bis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,7,11,16-pentaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadec-13-en-8-yl]purin-6-amine(Non-covalent)

98F.1: 25 residues within 4Å: Chain A: S.23, Y.24, G.27, Y.28, R.93, I.96, R.99, V.100, Y.101, T.124, P.125, T.128 Chain B: S.23, Y.24, G.27, Y.28, R.93, I.96, R.99, V.100, Y.101, T.124, P.125, T.128 Ligands: 98F.2 21 PLIP interactions: 12 interactions with chain B, 9 interactions with chain A Hydrogen bonds: B:R.99, B:V.100, B:T.128, A:R.93, A:R.99, A:V.100 Water bridges: B:S.23, B:S.23, B:R.93, B:S.102, B:S.102, A:S.23, A:S.102, A:S.102 Salt bridges: B:R.93, B:R.99 pi-Stacking: B:Y.28, A:Y.28, A:Y.28 pi-Cation interactions: B:R.99, A:R.99 98F.2: 25 residues within 4Å: Chain A: S.23, Y.24, G.27, Y.28, R.93, I.96, R.99, V.100, Y.101, T.124, P.125, T.128 Chain B: S.23, Y.24, G.27, Y.28, R.93, I.96, R.99, V.100, Y.101, T.124, P.125, T.128 Ligands: 98F.1 21 PLIP interactions: 10 interactions with chain B, 11 interactions with chain A Hydrogen bonds: B:R.93, B:R.99, B:V.100, B:T.128, A:R.99, A:V.100 Water bridges: B:S.23, B:S.102, B:S.102, A:S.23, A:S.23, A:R.93, A:S.102, A:S.102 pi-Stacking: B:Y.28, B:Y.28, A:Y.28 pi-Cation interactions: B:R.99, A:R.99 Salt bridges: A:R.93, A:R.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dejmek, M. et al., Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy. Eur.J.Med.Chem. (2023)

Release Date

2022-10-19

Peptides

Stimulator of interferon genes protein: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Stimulator of interferon genes protein

Related Entries With Identical Sequence